BIRC5 and neoplasm: The delivery of a pH-labile polymer complexed with plasmid DNA encoding Cas9 and a survivin-specific sgRNA was shown to sensitize the tumor to the anticancer drug, temozolomide, resulting in synergistic tumor suppression.